Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitors.
about
KU675, a Concomitant Heat-Shock Protein Inhibitor of Hsp90 and Hsc70 that Manifests Isoform Selectivity for Hsp90α in Prostate Cancer CellsA Scaffold Merging Approach to Hsp90 C-terminal Inhibition: Synthesis and Evaluation of a Chimeric Library.Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors.Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development.
P2860
Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Development of a high-throughp ...... identifying Hsp90 inhibitors.
@ast
Development of a high-throughp ...... identifying Hsp90 inhibitors.
@en
type
label
Development of a high-throughp ...... identifying Hsp90 inhibitors.
@ast
Development of a high-throughp ...... identifying Hsp90 inhibitors.
@en
prefLabel
Development of a high-throughp ...... identifying Hsp90 inhibitors.
@ast
Development of a high-throughp ...... identifying Hsp90 inhibitors.
@en
P2093
P2860
P356
P1476
Development of a high-throughp ...... identifying Hsp90 inhibitors.
@en
P2093
Bhaskar R Kusuma
Brian S J Blagg
Douglas Brown
George A Vielhauer
Huiping Zhao
Jeffery D Eskew
Jeffrey M Holzbeierlein
Megan Swink
Robert L Matts
Roger A Rajewski
P2860
P304
P356
10.1089/ADT.2012.498
P577
2013-10-15T00:00:00Z